- June 16, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") , a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announces that the previously announced episode of The Human Upgrade with Dave Asprey featuring Justin Kirkland, Chief Scientific Officer of the Company, is now available
In some embodiments, the otic formulation or composition comprises between about 0.01% to about 99.9% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof
Physician supervision is appropriate given the multiple active compounds
COA files are displayed as lot/documentation records for research review and are not medical, therapeutic, or human-use claims
Growth hormone peptides like Ipamorelin and CJC-1295 indirectly support repair through systemic GH/IGF-1 elevation promoting overall tissue anabolism, while direct application peptides like BPC-157 target local injury sites with concentrated effects
Patients should always follow the dosing instructions provided by their healthcare provider
